PROT-001 / Protego Biopharma - LARVOL DELTA

A Phase 1 Study of PROT-001. (clinicaltrials.gov) - P1 | N=102 | Not yet recruiting | Sponsor: Protego Biopharma Pty Ltd

First-in-human • New P1 trial

A Phase 1 Study of PROT-001. (clinicaltrials.gov) - P1 | N=124 | Completed | Sponsor: Protego Biopharma Pty Ltd | Recruiting ➔ Completed

First-in-human • Trial completion

A Phase 1 Study of PROT-001. (clinicaltrials.gov) - P1 | N=102 | Recruiting | Sponsor: Protego Biopharma Pty Ltd | Not yet recruiting ➔ Recruiting | Trial primary completion date: Oct 2025 ➔ Jan 2026

Enrollment open • First-in-human • Trial primary completion date